Impact of Dietary Soy Isoflavones in Pregnancy on Fetal Programming of Endothelial Function in Offspring

Microcirculation

Volumn 18, Issue 4, 2011, Pages 270-285

  Bonacasa, Barbara ^b   Siow, Richard C M ^a   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Daidzein; Developmental plasticity; Endothelial function; Endothelial nitric oxide synthase; Endothelium derived hyperpolarizing factor; Epigenetics; Equol; Fetal programming; Genistein; Gestational diabetes; Intrauterine growth restriction; Intrauterine programming; Isoflavones; Mitochondria; Nrf2; Pre eclampsia; Pregnancy; Redox signaling; Vascular protection

Indexed keywords

COUMESTROL; DAIDZEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENTEROLACTONE; EQUOL; GENISTEIN; ISOFLAVONE; TRANSCRIPTION FACTOR NRF2;

CARDIOVASCULAR DISEASE; CELL FUNCTION; COMPUTER PROGRAM; DIET SUPPLEMENTATION; ENDOTHELIUM; EPIGENETICS; FETUS; FETUS CIRCULATION; FETUS DEVELOPMENT; FETUS MONITORING; GENE EXPRESSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OXIDATION REDUCTION REACTION; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; FETAL DEVELOPMENT; HUMANS; ISOFLAVONES; MALE; OXIDATIVE STRESS; PREGNANCY; RATS; SOYBEANS;

RATTUS; RODENTIA;

EID: 79955143122     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2011.00088.x     Document Type: Review

References (160)

1. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 29: 95-120, 1997.
2. Adlercreutz H, Yamada T, Wahala K, Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol 180: 737-743, 1999.
3. Akingbemi BT, Braden TD, Kemppainen BW, Hancock KD, Sherrill JD, Cook SJ, He X, Supko JG. Exposure to phytoestrogens in the perinatal period affects androgen secretion by testicular Leydig cells in the adult rat. Endocrinology 148: 4475-4488, 2007.
4. Balakrishnan B, Thorstensen EB, Ponnampalam AP, Mitchell MD. Transplacental transfer and biotransformation of genistein in human placenta. Placenta 31: 506-511, 2010.
5. Barker DJ. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 13: 807-813, 1997.
6. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 13: 364-368, 2002.
7. Barker DJ. Developmental origins of adult health and disease. J Epidemiol Community Health 58: 114-115, 2004.
8. Barker DJ. The developmental origins of insulin resistance. Horm Res 64(Suppl. 3): 2-7, 2005.
9. Barker D. Commentary: birthweight and coronary heart disease in a historical cohort. Int J Epidemiol 35: 886-887, 2006.
10. Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2: 700-707, 2006.
11. Barker DJ, Gelow J, Thornburg K, Osmond C, Kajantie E, Eriksson JG. The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur J Heart Fail 12: 819-825, 2010.
12. Barker DJ, Osmond C. Childhood respiratory infection and adult chronic bronchitis in England and Wales. Br Med J (Clin Res Ed) 293: 1271-1275, 1986.
13. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298: 564-567, 1989.
14. Barnes SK, Ozanne SE. Pathways linking the early environment to long-term health and lifespan. Prog Biophys Mol Biol doi:10.1016/j.pbiomolbio.2010.12.005.
15. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 166: 506-510, 2007.
16. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 265: 1861-1867, 1991.
17. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 26: 995-1001, 2006.
18. Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley RA, Gluckman P, Godfrey K, Kirkwood T, Lahr MM, McNamara J, Metcalfe NB, Monaghan P, Spencer HG, Sultan SE. Developmental plasticity and human health. Nature 430: 419-421, 2004.
19. Beavers KM, Jonnalagadda SS, Messina MJ. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature. Nutr Rev 67: 213-221, 2009.
20. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 64: 187-192, 2007.
21. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27: 327-332, 2006.
22. Blay M, Espinel AE, Delgado MA, Baiges I, Blade C, Arola L, Salvado J. Isoflavone effect on gene expression profile and biomarkers of inflammation. J Pharm Biomed Anal 51: 382-390, 2010.
23. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30(Suppl. A): S43-S48, 2009.
24. Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di RL, Condorelli D, De LA, Calabrese EJ. The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16: 877-883, 2010.
25. Cao Y, Calafat AM, Doerge DR, Umbach DM, Bernbaum JC, Twaddle NC, Ye X, Rogan WJ. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol 19: 223-234, 2009.
26. Casanova M, You L, Gaido KW, rchibeque-Engle S, Janszen DB, Heck HA. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci 51: 236-244, 1999.
27. Cassidy A, Hooper L. Phytoestrogens and cardiovascular disease. J Br Menopause Soc 12: 49-56, 2006.
28. Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 304: 30-42, 2009.
29. Cederroth CR, Vinciguerra M, Gjinovci A, Kuhne F, Klein M, Cederroth M, Caille D, Suter M, Neumann D, James RW, Doerge DR, Wallimann T, Meda P, Foti M, Rohner-Jeanrenaud F, Vassalli JD, Nef S. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57: 1176-1185, 2008.
30. Chan WH. Impact of genistein on maturation of mouse oocytes, fertilization, and fetal development. Reprod Toxicol 28: 52-58, 2009.
31. Chaudhari L, Tandon OP, Vaney N, Agarwal N. Lipid peroxidation and antioxidant enzymes in gestational diabetics. Indian J Physiol Pharmacol 47: 441-446, 2003.
32. Cheng X, Siow RC, Mann GE. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal 14: 469-487, 2011.
33. Chin-Dusting JP, Boak L, Husband A, Nestel PJ. The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism. Atherosclerosis 176: 45-48, 2004.
34. Christie DR, Grant J, Darnell BE, Chapman VR, Gastaldelli A, Sites CK. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. Am J Obstet Gynecol 203: 153-159, 2010.
35. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25: 78-84, 2004.
36. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
37. Degen GH, Janning P, Diel P, Michna H, Bolt HM. Transplacental transfer of the phytoestrogen daidzein in DA/Han rats. Arch Toxicol 76: 23-29, 2002.
38. Doerge DR, Churchwell MI, Chang HC, Newbold RR, Delclos KB. Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reprod Toxicol 15: 105-110, 2001.
39. Doerge DR, Churchwell MI, Delclos KB. On-line sample preparation using restricted-access media in the analysis of the soy isoflavones, genistein and daidzein, in rat serum using liquid chromatography electrospray mass spectrometry. Rapid Commun Mass Spectrom 14: 673-678, 2000.
40. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 104: 13056-13061, 2007.
41. Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ Mol Mutagen 49: 4-8, 2008.
42. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114: 567-572, 2006.
43. Douglas G, Armitage JA, Taylor PD, Lawson JR, Mann GE, Poston L. Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat. J Physiol 571: 477-487, 2006.
44. Engel SM, Levy B, Liu Z, Kaplan D, Wolff MS. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 21: 110-112, 2006.
45. Essex C. Phytoestrogens and soy based infant formula. BMJ 313: 507-508, 1996.
46. Fall CH, Vijayakumar M, Barker DJ, Osmond C, Duggleby S. Weight in infancy and prevalence of coronary heart disease in adult life. BMJ 310: 17-19, 1995.
47. Figtree GA, Griffiths H, Lu YQ, Webb CM, MacLeod K, Collins P. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol 35: 1977-1985, 2000.
48. Forsen T, Eriksson JG, Tuomilehto J, Teramo K, Osmond C, Barker DJ. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ 315: 837-840, 1997.
49. Foster WG, Chan S, Platt L, Hughes CL Jr. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 129: 199-205, 2002.
50. Fujii M, Inoguchi T, Sasaki S, Maeda Y, Zheng J, Kobayashi K, Takayanagi R. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int 78: 905-919, 2010.
51. Galao AO, Wender MC, Ramos JG. Re: maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. J Perinatol 30: 301, 2010.
52. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20, 2009.
53. Geelhoed JJ, Fraser A, Tilling K, Benfield L, Davey SG, Sattar N, Nelson SM, Lawlor DA. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation 122: 1192-1199, 2010.
54. Gems D, Partridge L. Stress-response hormesis and aging: "that which does not kill us makes us stronger". Cell Metab 7: 200-203, 2008.
55. Gilbert ER, Liu D. Flavonoids influence epigenetic-modifying enzyme activity: structure-function relationships and the therapeutic potential for cancer. Curr Med Chem 17: 1756-1768, 2010.
56. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294: H541-H550, 2008.
57. Gluckman PD, Hanson MA. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15: 183-187, 2004.
58. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 71: 1344S-1352S, 2000.
59. Goval JJ, Alexandre H. Effect of genistein on the temporal coordination of cleavage and compaction in mouse preimplantation embryos. Eur J Morphol 38: 88-96, 2000.
60. Goval JJ, Van CA, Alexandre H. Respective roles of protein tyrosine kinases and protein kinases C in the upregulation of beta-catenin distribution, and compaction in mouse preimplantation embryos: a pharmacological approach. Biol Cell 92: 513-526, 2000.
61. Guerrero-Bosagna CM, Sabat P, Valdovinos FS, Valladares LE, Clark SJ. Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice. BMC Physiol 8: 17, 2008.
62. Hales CN. Fetal and infant growth and impaired glucose tolerance in adulthood: the "thrifty phenotype" hypothesis revisited. Acta Paediatr Suppl 422: 73-77, 1997.
63. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303: 1019-1022, 1991.
64. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1year after a pre-eclamptic pregnancy. J Hypertens 25: 2301-2307, 2007.
65. Heo JS, Han HJ. PKC and MAPKs pathways mediate EGF-induced stimulation of 2-deoxyglucose uptake in mouse embryonic stem cells. Cell Physiol Biochem 17: 145-158, 2006.
66. Hertrampf T, Ledwig C, Kulling S, Molzberger A, Moller FJ, Zierau O, Vollmer G, Moors S, Degen GH, Diel P. Responses of estrogen sensitive tissues in female Wistar rats to pre- and postnatal isoflavone exposure. Toxicol Lett 191: 181-188, 2009.
67. Hilakivi-Clarke L, Cho E, Cabanes A, DeAssis S, Olivo S, Helferich W, Lippman ME, Clarke R. Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. Clin Cancer Res 8: 3601-3610, 2002.
68. Hoey L, Rowland IR, Lloyd AS, Clarke DB, Wiseman H. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91: 607-616, 2004.
69. Hulley SB, Grady D. The WHI estrogen-alone trial-do things look any better? JAMA 291: 1769-1771, 2004.
70. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029, 2000.
71. Itoh K, Mimura J, Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 13: 1665-1678, 2010.
72. Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36: 1208-1213, 2004.
73. Jayet PY, Rimoldi SF, Stuber T, Salmon CS, Hutter D, Rexhaj E, Thalmann S, Schwab M, Turini P, Sartori-Cucchia C, Nicod P, Villena M, Allemann Y, Scherrer U, Sartori C. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 122: 488-494, 2010.
74. Jefferson WN, Doerge D, Padilla-Banks E, Woodling KA, Kissling GE, Newbold R. Oral exposure to genistin, the glycosylated form of genistein, during neonatal life adversely affects the female reproductive system. Environ Health Perspect 117: 1883-1889, 2009.
75. Jiang F, Roberts SJ, Datla S, Dusting GJ. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48: 950-957, 2006.
76. 2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J Biol Chem 281: 27335-27345, 2006.
77. Kaspar JW, Jaiswal AK. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J, doi: fj.10-171553, 2010.
78. Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol 29: 235-246, 2010.
79. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S.women: the Framingham study. J Nutr 132: 276-282, 2002.
80. Knight DC, Eden JA, Huang JL, Waring MA. Isoflavone content of infant foods and formulas. J Paediatr Child Health 34: 135-138, 1998.
81. Knight DC, Eden JA, Kelly GE. The phytoestrogen content of infant formulas. Med J Aust 164: 575, 1996.
82. Knock GA, Mahn K, Mann GE, Ward JP, Aaronson PI. Dietary soy modulates endothelium-dependent relaxation in aged male rats: increased agonist-induced endothelium-derived hyperpolarising factor and basal nitric oxide activity. Free Radic Biol Med 41: 731-739, 2006.
83. Krause B, Sobrevia L, Casanello P. Epigenetics: new concepts of old phenomena in vascular physiology. Curr Vasc Pharmacol 7: 513-520, 2009.
84. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
85. Kuiper GG, Gustafsson JA. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410: 87-90, 1997.
86. Lamartiniere CA, Wang J, Smith-Johnson M, Eltoum IE. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 65: 228-238, 2002.
87. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19: 1890-1892, 2005.
88. Lappas M, Mitton A, Permezel M. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J Endocrinol 204: 75-84, 2010.
89. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, Lithell UB, McKeigue PM. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 317: 241-245, 1998.
90. Levonen AL, Vahakangas E, Koponen JK, Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 117: 2142-2150, 2008.
91. Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat M, Stocker R, Croft KD. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 30: 749-757, 2010.
92. Lucas A. Programming by early nutrition in man. Ciba Found Symp 156: 38-50, 1991.
93. Lucas A. Role of nutritional programming in determining adult morbidity. Arch Dis Child 71: 288-290, 1994.
94. Lyall F. Priming and remodelling of human placental bed spiral arteries during pregnancy-a review. Placenta 26(Suppl. A): S31-S36, 2005.
95. Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest 65: 227-232, 2008.
96. Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D, Poston L, Ward JP, Sharpe RM, Vina J, Aaronson PI, Mann GE. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19: 1755-1757, 2005.
97. Mann GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol 9: 139-145, 2009.
98. Mann GE, Rowlands DJ, Li FY, de WP, Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 75: 261-274, 2007.
99. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83: 183-252, 2003.
100. Matulka RA, Matsuura I, Uesugi T, Ueno T, Burdock G. Developmental and reproductive effects of SE5-OH: an equol-rich soy-based ingredient. J Toxicol 2009: 307-618, 2009.
101. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279: 31556-31567, 2004.
102. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85: 571-633, 2005.
103. Moller FJ, Diel P, Zierau O, Hertrampf T, Maass J, Vollmer G. Long-term dietary isoflavone exposure enhances estrogen sensitivity of rat uterine responsiveness mediated through estrogen receptor alpha. Toxicol Lett 196: 142-153, 2010.
104. Mueller CF, Laude K, McNally JS, Harrison DG. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25: 274-278, 2005.
105. Mustafa AM, Malintan NT, Seelan S, Zhan Z, Mohamed Z, Hassan J, Pendek R, Hussain R, Ito N. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol Appl Pharmacol 222: 25-32, 2007.
106. Myatt L. Placental adaptive responses and fetal programming. J Physiol 572: 25-30, 2006.
107. Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31(Suppl.): S66-S69, 2010.
108. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost 7: 375-384, 2009.
109. Nagarajan S. Mechanisms of anti-atherosclerotic functions of soy-based diets. J Nutr Biochem 21: 255-260, 2010.
110. Nagarajan S, Burris RL, Stewart BW, Wilkerson JE, Badger TM. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 138: 332-337, 2008.
111. Nagata C, Iwasa S, Shiraki M, Ueno T, Uchiyama S, Urata K, Sahashi Y, Shimizu H. Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan). Cancer Causes Control 17: 1107-1113, 2006.
112. Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 39: 475-480, 1991.
113. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K, Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic Res 44: 1125-1171, 2010.
114. Neu J, Hauser N, Douglas-escobar M. Postnatal nutrition and adult health programming. Semin Fetal Neonatal Med 12: 78-86, 2007.
115. Newbold RR, Jefferson WN, Padilla-Banks E. Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117: 879-885, 2009.
116. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 51: 912-917, 2007.
117. Osmond C, Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 108(Suppl. 3): 545-553, 2000.
118. Osmond C, Barker DJ, Winter PD, Fall CH, Simmonds SJ. Early growth and death from cardiovascular disease in women. BMJ 307: 1519-1524, 1993.
119. Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr 93: 446-454, 2011.
120. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker OP. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351: 173-177, 1998.
121. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 308: 1592-1594, 2005.
122. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 315: 396-400, 1997.
123. Robertson TL, Kato H, Rhoads GG, Kagan A, Marmot M, Syme SL, Gordon T, Worth RM, Belsky JL, Dock DS, Miyanishi M, Kawamoto S. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 39: 239-243, 1977.
124. Rowlands DJ, Chapple S, Siow RC, Mann GE. Equol stimulated mitochondrial derived reactive oxygen species activate eNOS and redox signaling in endothelial cells: roles for F-actin and GPR30. Hypertension 57: 833-840, 2011.
125. 2+-homeostasis. Biochem Soc Trans 25: 112S, 1997.
126. 2+ channels in smooth muscle cells. FASEB J 12: 613-619, 1998.
127. Sacks FM, Lichtenstein A, Van HL, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the American Heart Association Nutrition Committee. Arterioscler Thromb Vasc Biol 26: 1689-1692, 2006.
128. Saker M, Soulimane MN, Merzouk SA, Merzouk H, Belarbi B, Narce M. Oxidant and antioxidant status in mothers and their newborns according to birthweight. Eur J Obstet Gynecol Reprod Biol 141: 95-99, 2008.
129. Scifres CM, Nelson DM. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 587: 3453-3458, 2009.
130. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333S-1346S, 1998.
131. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758S-767S, 1999.
132. Setchell KD, Zhao X, Shoaf SE, Ragland K. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr 139: 2037-2043, 2009.
133. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350: 23-27, 1997.
134. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68: 1453S-1461S, 1998.
135. Siow RC, Li FY, Rowlands DJ, de WP, Mann GE. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med 42: 909-925, 2007.
136. Siow RC, Mann GE. Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol Aspects Med 31: 468-477, 2010.
137. Sobrevia L, Cesare P, Yudilevich DL, Mann GE. Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 489(Pt 1): 183-192, 1995.
138. Sobrevia L, Yudilevich DL, Mann GE. Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies. J Physiol 506(Pt 1): 219-230, 1998.
139. Soucy NV, Parkinson HD, Sochaski MA, Borghoff SJ. Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 90: 230-240, 2006.
140. Souzeau E, Belanger S, Picard S, Deschepper CF. Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood. Am J Physiol Heart Circ Physiol 289: H715-H721, 2005.
141. 2+ channels. J Physiol Biochem 65: 113-124, 2009.
142. Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJ. Fetal growth and coronary heart disease in south India. Lancet 348: 1269-1273, 1996.
143. 2+ regulation in fetal vascular smooth muscle in pre-eclampsia: enhanced sensitivity to arachidonic acid. FASEB J 17: 307-309, 2003.
144. 2+ signaling in human endothelial and smooth muscle cells in pre-eclampsia. Antioxid Redox Signal 11: 1149-1163, 2009.
145. 2+ regulation and NO production in human fetal venous endothelial cells. FASEB J 16: 721-723, 2002.
146. Sugden MC, Holness MJ. Gender-specific programming of insulin secretion and action. J Endocrinol 175: 757-767, 2002.
147. Taille C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, Boczkowski J. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279: 28681-28688, 2004.
148. Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res 59: 320-324, 2006.
149. Todaka E, Sakurai K, Fukata H, Miyagawa H, Uzuki M, Omori M, Osada H, Ikezuki Y, Tsutsumi O, Iguchi T, Mori C. Fetal exposure to phytoestrogens-the difference in phytoestrogen status between mother and fetus. Environ Res 99: 195-203, 2005.
150. Tousen Y, Umeki M, Nakashima Y, Ishimi Y, Ikegami S. Effects of genistein, an isoflavone, on pregnancy outcome and organ weights of pregnant and lactating rats and development of their suckling pups. J Nutr Sci Vitaminol (Tokyo) 52: 174-182, 2006.
151. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285: 1929-1931, 1999.
152. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 444: 875-880, 2006.
153. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 103: 258-262, 2001.
154. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63-68, 2004.
155. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81: 243S-255S, 2005.
156. Woodman OL, Missen MA, Boujaoude M. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol 44: 155-163, 2004.
157. Wu G, Pond WG, Flynn SP, Ott TL, Bazer FW. Maternal dietary protein deficiency decreases nitric oxide synthase and ornithine decarboxylase activities in placenta and endometrium of pigs during early gestation. J Nutr 128: 2395-2402, 1998.
158. 2+-activated K+ channels in vascular smooth muscle cells. Eur J Pharmacol 630: 100-106, 2010.
159. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99: 2152-2164, 1997.
160. Zielinsky P, Piccoli AL Jr, Manica JL, Nicoloso LH, Menezes H, Busato A, Moraes MR, Silva J, Bender L, Pizzato P, Aita L, Alievi M, Vian I, Almeida L. Maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. J Perinatol 30: 17-21, 2010.